Yahoo
NYSE - Nasdaq Real Time Price USD

Novo Nordisk A/S (NVO)

40.00 +0.86 (+2.20%)
At close: October 30 at 4:00:02 PM EDT
39.97 -0.03 (-0.07%)
After hours: October 30 at 7:58:28 PM EDT
Trade NVO on Coinbase

News headlines

Updated 44m ago
Powered by Yahoo Scout

Novo Nordisk faces a tougher competitive environment after Eli Lilly reported stronger retatrutide trial results against Ozempic. Analysts and valuation models disagree sharply, while Novo is expanding its pipeline and setting longer-term goals to reduce reliance on existing GLP-1 products.[1][2][3]

Mobilize your Website
View Site in Mobile | Classic
Share by: